According to Future Market Insights (FMI), the global Whole Genome Amplification Market sales would hit US$ 5.5 billion by the end of 2033, owing to the increased demand for Whole Genome Amplification in forensics and genetic disorders. The market is estimated to be worth US$ 2.8 billion by 2023, with a 7.0% CAGR between 2023 and 2033.
“On-chip cell capture and DNA extraction,” a new technology for Whole Genome Amplification, collects chromosomal DNA from single cells after extraction and fixes it in a micropillar array for isothermal amplification. Single cell on-chip WGA is intended to overcome the amplification biases of traditional single cell WGA and improve genome coverage, particularly in cancer cell genomes.
Make Informed Decisions in the Genomics Industry. Grab a Sample Copy of the Whole Genome Amplification Market Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1873
Various WGA kits’ ease of use throughout the entire process has boosted the market over the years. Molecular testing firms are increasingly focused on producing novel devices and kits, such as WGA kits and complete WGA kits with expanded capabilities, to increase their revenue share. Because it provides a more advanced way of genome amplification and sequencing, use of this technology is projected to accelerate among research institutes, hospitals, diagnostic centres, and forensic labs.
Single Cell WGA Continues to Bring in New Applications:
The massively parallel sequencing of single-cell genomes is expected to broaden our understanding of genetic variation in complex biological systems.
Single cell WGA is a technique that examines sequence information from a single cell using powerful next generation sequencing technologies. This approach is considered as a valuable tool for researching genetics since it brings the entire genome structure to a cellular level.
Because this technology generates a high-resolution image of the genomic material, it will be used in a variety of scientific fields, including microbiology, immunology, neuroscience, cancer research, and tissue mosaicism.
They are also looking for distribution and collaboration agreements to help improve their product reach. It will also help them serve end users better, with diagnostic consulting and good laboratory practices. High price point may remain a major challenge for companies.
Whole Genome Amplification Market Report Available At a Discounted Price: https://www.futuremarketinsights.com/request-discount/rep-gb-1873
Whole Genome Amplification Market Major Players:
- GE Healthcare
- Sygnis AG
- Illumina, Inc.
- Merck KGaA
- Thermo Fisher Scientific Inc
Key Segments Covered in Whole Genome Amplification Market Study:
By Product Type
- Single Cell WGA Kit
- Complete WGA Kit
- WGA Re-Amplification Kit
- WGA & Chip DNA Kit
- Others
By Application
- Drug Discovery & Development
- Disease Diagnosis
- Agriculture & Veterinary
- Research
- Forensics
- Others
By End User
- Pharma & Biotech Companies
- Hospitals & Clinics
- Contract Research
- Organizations
- Research & Academic Institutes
- Others
Customize Your Report Now: https://www.futuremarketinsights.com/customization-available/rep-gb-1873
About Future Market Insights, Inc.
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn | Twitter | Blogs
